Church and therapy join forces to fight depression in black communities

NCT ID NCT06292637

Recruiting now Symptom relief Sponsor: University of Wisconsin, Madison Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new depression treatment that combines cognitive behavioral therapy with faith-based principles, delivered by therapists and pastors in church settings. It aims to reduce depressive symptoms in African American adults. The trial will enroll 50 participants and measure changes in depression severity using standard questionnaires.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Cognitive behavioral therapy combined with faith-based principles, delivered by therapists and pastors
What this could lead to: If it works, this could provide a culturally tailored, evidence-based option for treating depression in African American communities.
What could go wrong: This is a small feasibility study with only 50 participants, so results may not apply broadly. It is not yet proven to work better than standard treatments.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Depression depressive disorder major depressive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DEPRESSION

Contacts and locations

Locations

Second Baptist Church
RECRUITING

Madison, Wisconsin, 53711-3800, United States
The Board of Regents of the UW System
RECRUITING

Madison, Wisconsin, 53715-1218, United States
University of Wisconsin - Madison
RECRUITING

Madison, Wisconsin, 53515, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.